The statistical results showed that the fluctuation of CD4/CD8 cell ratios during tumor progression after vaccination was significant and may reflect more rigorous and dynamic immune regulation and activity in the Treatment group (Fig. 3Aa and Bc). Here, CD8A is linked to neoplasm.